Sanofi

Open: 53.32 Close: 52.59 Change: -0.73

The best way to get information about Sanofi Company Inc Stock: Use an AI.

This document will help you to evaluate Sanofi without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sanofi are: Sanofi, patent, Supreme, Court, Amgen, cholesterol, drug, and the …

Concept Map

Semantic Network

Stock Summary

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company also provides cough, cold.

Today's Summary

U.S. Supreme Court rules against Amgen in cholesterol drug patent dispute with sanofi. The contentious battle is centred around two monoclonal antibodies that inhibit the protein PCSK9.

Today's News

U.S. Supreme Court rules against Amgen in cholesterol drug patent dispute with sanofi. Supreme Court Rules Against Amgen In Cholesterol Drug Patent Dispute With Sanofi. The contentious battle is centred around two monoclonal antibodies that inhibit the protein PCSK9, which in turn lowers low-density lipoprotein (LDL) cholesterol levels. Sanofi leaves legal standard for patent enablement Undisturbed Cooley Alert May 23, 2023. Sanofi SA is a healthcare company based in France. Analysts covering Sanofi SA have a consensus Earnings Per Share (EPS) forecast of €8.23 for the next financial year. The analyst consensus target price for shares in Sanofi is €107.10. Kymab-originated amlitelimab is being tested in both type 2 and non-type 2 patients. SAR-765 is a bispecific nanobody targeting IL-13 and TSLP, two binding domains that create the potential for “the most effective biologic for asthma” Sanofi believes the project has the potential to preserve lung function. Sanofi: smokers lung drug benefit was swift and sustained in trial. Sanofi presented details on the successful study at the American Thoracic Society congress in Washington over the weekend. In amgen-sanofi decision, high court sticks to patent law script. Ruling encourages longer, more specific patent applications.

Stock Profile

"Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France."

Keywords

The game is changing. There is a new strategy to evaluate Sanofi fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sanofi are: Sanofi, patent, Supreme, Court, Amgen, cholesterol, drug, and the most common words in the summary are: sap, sanofi, patent, news, stock, management, data, . One of the sentences in the summary was: Supreme Court rules against Amgen in cholesterol drug patent dispute with sanofi. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #sap #sanofi #patent #news #stock #management #data.